Effect of the aquaretic vasopressin antagonists d(CH2)5[D-Tyr(Et)2-Val4]AVP and d(CH2)5[D-Phe2-Phe4]AVP on urine production in healthy dogs.
van Oosterhout
I C
IC
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht, The Netherlands.
Rijnberk
A
A
Mol
J A
JA
D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004285:Dogs; D005260:Female; D009994:Osmolar Concentration; D012964:Sodium / Q000097:blood / Q000652:urine; D014563:Urodynamics / Q000187:drug effects*; D014667:Vasopressins / Q000037:antagonists & inhibitors* / Q000097:blood
D014667:Vasopressins; D001127:Arginine Vasopressin; C028884:1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(O-ethyl-Tyr)-4-Val-arginine vasopressin; C077192:argipressin, d(CH2)5-Phe(2,4)-; D012964:Sodium